Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Millerknoll (MLKN) Asset Writedowns and Impairment (2020 - 2025)

Millerknoll's Asset Writedowns and Impairment history spans 4 years, with the latest figure at $125.6 million for Q2 2025.

  • For Q2 2025, Asset Writedowns and Impairment rose 816.79% year-over-year to $125.6 million; the TTM value through May 2025 reached $182.3 million, up 342.48%, while the annual FY2025 figure was $130.0 million, 673.81% up from the prior year.
  • Asset Writedowns and Impairment for Q2 2025 was $125.6 million at Millerknoll, up from $13.7 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $125.6 million in Q2 2025 and bottomed at -$15.5 million in Q2 2022.
  • The 4-year median for Asset Writedowns and Impairment is $21.5 million (2023), against an average of $33.4 million.
  • The largest annual shift saw Asset Writedowns and Impairment changed 0.0% in 2024 before it skyrocketed 816.79% in 2025.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at -$15.5 million in 2022, then skyrocketed by 238.71% to $21.5 million in 2023, then tumbled by 36.28% to $13.7 million in 2024, then surged by 816.79% to $125.6 million in 2025.
  • Per Business Quant, the three most recent readings for MLKN's Asset Writedowns and Impairment are $125.6 million (Q2 2025), $13.7 million (Q2 2024), and $21.5 million (Q1 2024).